Drug intelligence / Profile preview

Lubristil + Air Optix Night & Day

Development stage
Discontinued
Lead developer
Alcon
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

This combination regimen refers to the conventional treatment control arm used in clinical trials for neurotrophic keratopathy, specifically the Phase I/II trial NCT03084861 conducted by Banc de Sang i Teixits. The regimen consists of Lubristil, a lubricant eye drop (artificial tears) containing sodium hyaluronate, and Air Optix Night & Day, a silicone hydrogel therapeutic contact lens. Lubristil acts as an ocular lubricant to stabilize the tear film and hydrate the ocular surface, while the Air Optix Night & Day lens serves as a physical bandage to protect the compromised corneal epithelium from mechanical trauma and promote re-epithelialization in patients with stage 2 or 3 neurotrophic keratopathy.

Brand names
LubristilAir Optix Night & Day
Other names
conventional treatment-Banc de Sang i Teixits-neurotrophic keratopathyConventional treatment (artificial tears and therapeutic contact lens)
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on Lubristil + Air Optix Night & Day.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lubristil + Air Optix Night & Day.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call